vs
FIRST COMMUNITY BANKSHARES INC（FCBC）与PUMA BIOTECHNOLOGY, INC.（PBYI）财务数据对比。点击上方公司名可切换其他公司
PUMA BIOTECHNOLOGY, INC.的季度营收约是FIRST COMMUNITY BANKSHARES INC的1.7倍（$75.5M vs $43.8M），PUMA BIOTECHNOLOGY, INC.同比增速更快（27.7% vs 5.1%），FIRST COMMUNITY BANKSHARES INC自由现金流更多（$60.0M vs $14.4M），过去两年PUMA BIOTECHNOLOGY, INC.的营收复合增速更高（31.3% vs 3.5%）
第一社区银行控股公司是美国一家银行控股公司，总部位于弗吉尼亚州，为布卢菲尔德第一社区银行的母公司。截至2012年，该集团旗下网点分布在弗吉尼亚州、西弗吉尼亚州和田纳西州，截至2023年4月，集团总资产达36亿美元。
彪马生物技术是一家公开上市的生物制药企业，总部位于美国加利福尼亚州洛杉矶，专注于创新药物研发相关业务，在生物制药领域开展研发与商业化运营。
FCBC vs PBYI — 直观对比
营收规模更大
PBYI
是对方的1.7倍
$43.8M
营收增速更快
PBYI
高出22.6%
5.1%
自由现金流更多
FCBC
多$45.6M
$14.4M
两年增速更快
PBYI
近两年复合增速
3.5%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $43.8M | $75.5M |
| 净利润 | $12.5M | — |
| 毛利率 | — | 69.3% |
| 营业利润率 | 36.8% | 22.7% |
| 净利率 | 28.5% | — |
| 营收同比 | 5.1% | 27.7% |
| 净利润同比 | -4.4% | — |
| 每股收益（稀释后） | $0.67 | $0.26 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收FCBCPBYI
| Q4 25 | $43.8M | $75.5M | ||
| Q3 25 | $42.2M | $54.5M | ||
| Q2 25 | $41.0M | $52.4M | ||
| Q1 25 | $40.5M | $46.0M | ||
| Q4 24 | $41.7M | $59.1M | ||
| Q3 24 | $42.0M | $80.5M | ||
| Q2 24 | $41.3M | $47.1M | ||
| Q1 24 | $40.9M | $43.8M |
净利润FCBCPBYI
| Q4 25 | $12.5M | — | ||
| Q3 25 | $12.3M | $8.8M | ||
| Q2 25 | $12.2M | $5.9M | ||
| Q1 25 | $11.8M | $3.0M | ||
| Q4 24 | $13.0M | — | ||
| Q3 24 | $13.0M | $20.3M | ||
| Q2 24 | $12.7M | $-4.5M | ||
| Q1 24 | $12.8M | $-4.8M |
毛利率FCBCPBYI
| Q4 25 | — | 69.3% | ||
| Q3 25 | — | 77.7% | ||
| Q2 25 | — | 76.5% | ||
| Q1 25 | — | 77.1% | ||
| Q4 24 | — | 76.4% | ||
| Q3 24 | — | 63.9% | ||
| Q2 24 | — | 77.4% | ||
| Q1 24 | — | 75.5% |
营业利润率FCBCPBYI
| Q4 25 | 36.8% | 22.7% | ||
| Q3 25 | 37.7% | 17.6% | ||
| Q2 25 | 38.6% | 12.7% | ||
| Q1 25 | 37.7% | 8.7% | ||
| Q4 24 | 39.6% | 22.6% | ||
| Q3 24 | 39.3% | 27.4% | ||
| Q2 24 | 39.3% | -4.6% | ||
| Q1 24 | 40.3% | -5.3% |
净利率FCBCPBYI
| Q4 25 | 28.5% | — | ||
| Q3 25 | 29.1% | 16.2% | ||
| Q2 25 | 29.9% | 11.2% | ||
| Q1 25 | 29.2% | 6.5% | ||
| Q4 24 | 31.3% | — | ||
| Q3 24 | 31.0% | 25.2% | ||
| Q2 24 | 30.8% | -9.6% | ||
| Q1 24 | 31.4% | -11.0% |
每股收益（稀释后）FCBCPBYI
| Q4 25 | $0.67 | $0.26 | ||
| Q3 25 | $0.67 | $0.17 | ||
| Q2 25 | $0.67 | $0.12 | ||
| Q1 25 | $0.64 | $0.06 | ||
| Q4 24 | $0.67 | $0.40 | ||
| Q3 24 | $0.71 | $0.41 | ||
| Q2 24 | $0.71 | $-0.09 | ||
| Q1 24 | $0.71 | $-0.10 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | — | $97.5M |
| 总债务越低越好 | — | $22.7M |
| 股东权益账面价值 | $500.5M | $130.3M |
| 总资产 | $3.3B | $216.3M |
| 负债/权益比越低杠杆越低 | — | 0.17× |
8季度趋势，按日历期对齐
现金及短期投资FCBCPBYI
| Q4 25 | — | $97.5M | ||
| Q3 25 | — | $94.4M | ||
| Q2 25 | — | $96.0M | ||
| Q1 25 | — | $93.2M | ||
| Q4 24 | — | $101.0M | ||
| Q3 24 | — | $96.7M | ||
| Q2 24 | — | $96.8M | ||
| Q1 24 | — | $107.2M |
总债务FCBCPBYI
| Q4 25 | — | $22.7M | ||
| Q3 25 | $0 | $34.0M | ||
| Q2 25 | $0 | $45.3M | ||
| Q1 25 | $0 | $56.7M | ||
| Q4 24 | $0 | $68.0M | ||
| Q3 24 | $0 | $79.3M | ||
| Q2 24 | $0 | $90.7M | ||
| Q1 24 | $0 | $102.0M |
股东权益FCBCPBYI
| Q4 25 | $500.5M | $130.3M | ||
| Q3 25 | $510.7M | $115.3M | ||
| Q2 25 | $502.8M | $104.7M | ||
| Q1 25 | $496.4M | $97.1M | ||
| Q4 24 | $526.4M | $92.1M | ||
| Q3 24 | $520.7M | $71.1M | ||
| Q2 24 | $508.9M | $48.5M | ||
| Q1 24 | $506.9M | $51.0M |
总资产FCBCPBYI
| Q4 25 | $3.3B | $216.3M | ||
| Q3 25 | $3.2B | $202.9M | ||
| Q2 25 | $3.2B | $194.9M | ||
| Q1 25 | $3.2B | $196.2M | ||
| Q4 24 | $3.3B | $213.3M | ||
| Q3 24 | $3.2B | $220.7M | ||
| Q2 24 | $3.2B | $205.0M | ||
| Q1 24 | $3.2B | $214.1M |
负债/权益比FCBCPBYI
| Q4 25 | — | 0.17× | ||
| Q3 25 | 0.00× | 0.30× | ||
| Q2 25 | 0.00× | 0.43× | ||
| Q1 25 | 0.00× | 0.58× | ||
| Q4 24 | 0.00× | 0.74× | ||
| Q3 24 | 0.00× | 1.12× | ||
| Q2 24 | 0.00× | 1.87× | ||
| Q1 24 | 0.00× | 2.00× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $62.7M | $14.4M |
| 自由现金流经营现金流 - 资本支出 | $60.0M | $14.4M |
| 自由现金流率自由现金流/营收 | 137.0% | 19.1% |
| 资本支出强度资本支出/营收 | 6.3% | 0.0% |
| 现金转化率经营现金流/净利润 | 5.03× | — |
| 过去12个月自由现金流最近4个季度 | $100.6M | $41.7M |
8季度趋势，按日历期对齐
经营现金流FCBCPBYI
| Q4 25 | $62.7M | $14.4M | ||
| Q3 25 | $18.9M | $9.7M | ||
| Q2 25 | $10.2M | $14.1M | ||
| Q1 25 | $13.2M | $3.6M | ||
| Q4 24 | $57.7M | $15.6M | ||
| Q3 24 | $11.4M | $11.0M | ||
| Q2 24 | $14.5M | $1.0M | ||
| Q1 24 | $16.9M | $11.2M |
自由现金流FCBCPBYI
| Q4 25 | $60.0M | $14.4M | ||
| Q3 25 | $18.5M | $9.7M | ||
| Q2 25 | $10.0M | $14.1M | ||
| Q1 25 | $12.1M | $3.6M | ||
| Q4 24 | $54.9M | $15.6M | ||
| Q3 24 | $10.9M | $11.0M | ||
| Q2 24 | $14.1M | $1.0M | ||
| Q1 24 | $15.2M | — |
自由现金流率FCBCPBYI
| Q4 25 | 137.0% | 19.1% | ||
| Q3 25 | 43.9% | 17.7% | ||
| Q2 25 | 24.3% | 26.8% | ||
| Q1 25 | 29.8% | 7.7% | ||
| Q4 24 | 131.8% | 26.4% | ||
| Q3 24 | 26.0% | 13.7% | ||
| Q2 24 | 34.1% | 2.1% | ||
| Q1 24 | 37.1% | — |
资本支出强度FCBCPBYI
| Q4 25 | 6.3% | 0.0% | ||
| Q3 25 | 1.0% | 0.0% | ||
| Q2 25 | 0.6% | 0.0% | ||
| Q1 25 | 2.8% | 0.1% | ||
| Q4 24 | 6.7% | 0.0% | ||
| Q3 24 | 1.2% | 0.0% | ||
| Q2 24 | 0.9% | 0.0% | ||
| Q1 24 | 4.4% | 0.0% |
现金转化率FCBCPBYI
| Q4 25 | 5.03× | — | ||
| Q3 25 | 1.54× | 1.10× | ||
| Q2 25 | 0.83× | 2.41× | ||
| Q1 25 | 1.12× | 1.21× | ||
| Q4 24 | 4.43× | — | ||
| Q3 24 | 0.88× | 0.54× | ||
| Q2 24 | 1.14× | — | ||
| Q1 24 | 1.32× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
